Abiopharma

Almonty Industries Joins Large-Cap Russell 1000® Index and Broad-Market Russell 3000® Index

Twin Disc, Inc. Joins Russell 2000® and Russell 3000® Indexes

HONEYWELL TECHNOLOGIES TO RELEASE SECOND QUARTER FINANCIAL RESULTS, DISCUSS 2026 OUTLOOK AND HOLD ITS INVESTOR CONFERENCE CALL ON THURSDAY, JULY 23

Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer

Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD)

Dyadic Expands IP Protection and Business Development Activities in Japan

Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD)

Dyadic Expands IP Protection and Business Development Activities in Japan

Net Asset Value(s)

Private placement of 430,835 to employees, officers and CEO